title: Type 1 diabetes mellitus: an imbalance between effector and regulatory T cells?
abstract: Abundant evidence now exists that autoimmunity plays a critical role in the pathogenesis of type 1 (insulin-dependent) diabetes mellitus. The non-obese diabetic (NOD) mouse is an extensively studied animal model of this T-cell-mediated autoimmune disease. Our laboratory has focused on isolating diabetogenic T cell clones from NOD mice as a means of elucidating the pathogenesis of type 1 diabetes. This experimental approach presupposes that type 1 diabetes in NOD mice results from the action of islet-reactive T cells that are not present in other mouse strains; the diabetogenic T cells would therefore represent "forbidden clones" which exist in NOD mice as a result of a failure of clonal deletion. While the inappropriate presence of diabetogenic T cells probably plays a central role in murine diabetes, it cannot explain all aspects of the disease. Type 1 diabetes is a chronic disorder with a lengthy preclinical stage; if the diabetogenic T cells acted in an unopposed fashion, one might expect to see a much more fulminant clinical course. This observation suggests that regulatory influences are likely to exist in this disease--a possibility supported by recent experimental data. If these regulatory influences could be identified and enhanced, specific immunotherapy for type 1 diabetes could be achieved.
authors.affiliation: Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.
authors.forename: E J
authors.initials: EJ
authors.lastname: Rashba
authors.forename: E P
authors.initials: EP
authors.lastname: Reich
authors.forename: C A
authors.initials: CA
authors.lastname: Janeway
authors.forename: R S
authors.initials: RS
authors.lastname: Sherwin
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000097:blood*; D002648:Child; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000209:etiology / Q000276:immunology*; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D007249:Inflammation; D007515:Islets of Langerhans / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D051379:Mice; D016688:Mice, Inbred NOD; D010182:Pancreatic Diseases / Q000473:pathology / Q000503:physiopathology; D013601:T-Lymphocytes / Q000276:immunology / Q000502:physiology*; D014777:Virus Diseases / Q000150:complications
chemical_list: D001323:Autoantibodies